Vaccine advisers to the US Food and Drug Administration decided Tuesday that authorizing Novavax s Covid-19 vaccine which uses different technology from the three vaccines currently in use in the
After more than a year with two types of Covid-19 vaccines in use in the United States, another will be up for consideration by the US Food and Drug Administration
The US Centers for Disease Control and Prevention is clarifying the Covid-19 vaccination schedule for people who are moderately to severely immunocompromised, it said Friday, to address some of the
Data from a real-world study assessing Johnson & Johnson s Covid-19 vaccine finds it is 73.6% effective, according to research published Tuesday in the journal JAMA Network Open.